NCT04075513 - Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring in Type 1 Diabetes Patients | Biotech Hunter

Enrollment

343

Participants

Timeline

Start Date

October 9, 2019

Primary Completion Date

September 16, 2021

Study Completion Date

September 16, 2021

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG

Insulin glargine, 300 U/ml

"Pharmaceutical form: solution for injection in a prefilled pen~Route of administration: SC injection"

DRUG

Insulin degludec, 100U/ml

"Pharmaceutical form: solution for injection in a prefilled pen~Route of administration: SC injection"

DRUG

Background therapy: Rapid acting insulin analogs

Route of administration: SC injection

Trial Locations (7)

United States, Dallas

Investigational site BRAZIL, Brazil

Investigational site Germany, Germany

Investigational site Hungary, Hungary

Investigational site Netherlands, Netherlands

Investigational site Turkey, Turkey

Investigational site United Kingdom, United Kingdom